NKTR
Nektar Therapeutics · Healthcare
Director Jeffrey Robert Ajer sold $65K of Nektar Therapeutics
Sold$65,164
$17.78Price
3,665Shares
−10%Stake
What NKTR did after the filing
- The stock from Fri, Sep 24 close, $277.65
- −27.3%
- S&P 500, same days
- +5.5%
Measured over 30 trading days, to the Nov 5 close.
Traded Wed, Sep 22. Filed Fri, Sep 24, 2:12 PM ET, during the session. Returns use the Sep 24 close and the Nov 5 close. Not investment advice.